Tema Cardiovascular and Metabolics ETF (HRTS) Holdings $28.61 -0.40 (-1.38%) As of 03:58 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 46 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$788.62-3.6%10.08%7,3812UNHUnitedHealth Group$540.87+3.4%5.79%6,9873Novo Nordisk A/SN/A4.43%34,5084AstraZeneca PLCN/A4.22%17,0225BBIOBridgeBio Pharma$34.07-1.6%3.97%72,1516RHHBYRoche$40.02+1.7%3.95%56,1887VRTXVertex Pharmaceuticals$484.01+0.1%3.94%4,7668ABTAbbott Laboratories$131.57-0.3%3.59%17,4459Chugai Pharmaceutical Co., Ltd.N/A3.17%43,13110TMOThermo Fisher Scientific$469.88-3.9%3.11%3,695 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 11MDTMedtronic$87.89-1.1%3.01%20,39012BSXBoston Scientific$98.51-1.5%3.00%18,20613Novartis AGN/A2.89%15,76614MRKMerck & Co., Inc.$86.32-0.3%2.77%18,06715GILDGilead Sciences$112.39+0.4%2.62%15,27016CRNXCrinetics Pharmaceuticals$28.87-8.0%2.55%45,74117ABBVAbbVie$201.31-1.9%2.40%6,97918CYTKCytokinetics$40.52+0.7%2.28%32,58819DHRDanaher$197.75-3.6%2.03%5,96420BMYBristol-Myers Squibb$57.71-3.2%2.01%20,51321EWEdwards Lifesciences$73.03+1.4%1.90%16,54322ALNYAlnylam Pharmaceuticals$262.16-1.8%1.85%4,49323AMGNAmgen$309.85+1.4%1.82%3,57124REGNRegeneron Pharmaceuticals$610.64-2.4%1.82%1,69625PODDInsulet$256.80-4.6%1.78%4,13426MCKMcKesson$716.71+3.3%1.70%1,57427ASNDAscendis Pharma A/S$150.09-1.4%1.62%6,10628DXCMDexCom$61.80-9.3%1.59%13,04029MREOMereo BioPharma Group$2.21-6.8%1.32%317,06130MASIMasimo$152.37-11.1%1.25%4,54331MDGLMadrigal Pharmaceuticals$327.10-2.2%1.24%2,27832INSMInsmed$73.33-0.1%1.17%9,18133Zealand Pharma A/SN/A1.04%7,82634IONSIonis Pharmaceuticals$28.52-0.7%0.89%16,82335MIRMMirum Pharmaceuticals$43.23-3.9%0.89%11,43236VKTXViking Therapeutics$24.22-5.7%0.88%19,23137AKROAkero Therapeutics$39.99-4.7%0.85%11,77838WSTWest Pharmaceutical Services$219.84-0.8%0.84%2,26939GPCRStructure Therapeutics$16.33-3.7%0.80%22,59040RCKTRocket Pharmaceuticals$5.56-11.7%0.79%58,898DOGE tax surprise (Ad)Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.Move now and you could get in first - with huge upside potential.41ARWRArrowhead Pharmaceuticals$12.06-5.0%0.73%29,89342Gubra A/SN/A0.50%4,23843MTSRMetsera$21.15-6.7%0.28%6,23944NTLAIntellia Therapeutics$6.89-5.6%0.27%18,86045First American Treasury Obligations FundN/A0.22%138,35446DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.15%309,323,596 Geographic ExposureUnited States82.0%Denmark5.0%United Kingdom4.2%Ireland3.1%Switzerland3.0%Japan2.1%Currency ExposureUSD85.1%DKK5.5%GBP4.2%CHF3.0%JPY2.1%Sector ExposureHealth Care87.0%Industry ExposureBiotechnology53.3%Health Care Equipment & Supplies22.7%Health Care Providers & Services6.2%Pharmaceuticals3.0%Health Care Technology1.8%SubIndustry ExposureBiotechnology48.0%Health Care Equipment12.8%Life Sciences Tools & Services9.0%Pharmaceuticals6.9%Managed Health Care6.2%Health Care Distributors1.8%Health Care Supplies0.8%Coupon Exposure4-61.1%Maturity Exposure15-201.1% Related Companies and Tools Related Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies Tema Electrification ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Global X U.S. Electrification ETF Portfolio Companies SPDR Galaxy Hedged Digital Asset Ecosystem ETF Portfolio Companies Tema Oncology ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Global X Genomics & Biotechnology ETF Portfolio Companies Procure Space ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
